TD Securities (USA)’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$4K Buy
64
+1
+2% +$54 0.04% 266
2015
Q4
$4K Sell
63
-98
-61% -$6.18K 0.04% 266
2015
Q3
$10K Sell
161
-113,287
-100% -$8.09M 0.09% 241
2015
Q2
$8.29M Buy
113,448
+12,401
+12% +$896K 0.11% 215
2015
Q1
$6.61M Sell
101,047
-7,524
-7% -$500K 0.1% 249
2014
Q4
$7.06M Buy
108,571
+8,988
+9% +$579K 0.1% 246
2014
Q3
$5.99M Buy
99,583
+223
+0.2% +$14.6K 0.1% 241
2014
Q2
$6.88M Buy
99,360
+6,227
+7% +$404K 0.11% 215
2014
Q1
$6.09M Sell
93,133
-9,822
-10% -$639K 0.11% 223
2013
Q4
$6.38M Buy
102,955
+4,625
+5% +$268K 0.11% 222
2013
Q3
$5.27M Buy
98,330
+1,711
+2% +$88.1K 0.1% 244
2013
Q2
$4.41M Buy
+96,619
New +$4.19M 0.09% 279

Other funds holding STJ

TD Securities (USA)'s STJ Position: Q1 2016 in Review

TD Securities (USA) increased its St Jude Medical (STJ) stake by 1.6% in Q1 2016, buying an estimated $54 and bringing the position to 64 shares worth $4K. The position accounts for 0.04% of the portfolio, ranked #266.

TD Securities (USA) first reported a position in STJ in Q2 2013 and has held it in 12 quarters since. The position peaked at $8.29M in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • TD Securities (USA) held 64 shares of St Jude Medical worth $4K as of Q1 2016.
  • TD Securities (USA) bought 1 St Jude Medical share in Q1 2016, an estimated $54.
  • St Jude Medical made up 0.04% of TD Securities (USA)'s portfolio in Q1 2016, its #266 holding.
  • TD Securities (USA) first reported a position in St Jude Medical in Q2 2013 and has held it in 12 quarters since.
  • TD Securities (USA)'s St Jude Medical position peaked at $8.29M in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.